{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T05:08:58Z","timestamp":1705640938348},"reference-count":10,"publisher":"American Medical Association (AMA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Oncol"],"published-print":{"date-parts":[[2024,1,1]]},"abstract":"<jats:p>A 31-year-old man presented with left cervical and left inguinal masses and intermittent itching and night sweats for 2 years. What is your diagnosis?<\/jats:p>","DOI":"10.1001\/jamaoncol.2023.4045","type":"journal-article","created":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T15:01:51Z","timestamp":1697727711000},"page":"129","source":"Crossref","is-referenced-by-count":0,"title":["A Young Man With a Neck Mass and Hypereosinophilia"],"prefix":"10.1001","volume":"10","author":[{"given":"Maha","family":"Hameed","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Florida State University\/Sarasota Memorial Hospital, Sarasota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nasir","family":"Bakshi","sequence":"additional","affiliation":[{"name":"Department of Pathology, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mansour","family":"Alfayez","sequence":"additional","affiliation":[{"name":"Oncology Centre, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"issue":"7","key":"ccg230005r1","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours.","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"issue":"6","key":"ccg230005r2","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1038\/sj.leu.2404662","article-title":"Recurrent finding of the FIP1L1-PDGFRA fusion gene in eosinophilia-associated acute myeloid leukemia and lymphoblastic T-cell lymphoma.","volume":"21","author":"Metzgeroth","year":"2007","journal-title":"Leukemia"},{"issue":"10","key":"ccg230005r3","doi-asserted-by":"publisher","first-page":"3038","DOI":"10.1182\/blood-2004-03-0787","article-title":"FIP1L1-PDGFRA fusion.","volume":"104","author":"Pardanani","year":"2004","journal-title":"Blood"},{"issue":"9","key":"ccg230005r4","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1007\/s00277-017-3067-x","article-title":"Imatinib in myeloid\/lymphoid neoplasms with eosinophilia and rearrangement of PDGFRB in chronic or blast phase.","volume":"96","author":"Jawhar","year":"2017","journal-title":"Ann Hematol"},{"issue":"11","key":"ccg230005r5","doi-asserted-by":"publisher","first-page":"4635","DOI":"10.1182\/blood-2006-10-050054","article-title":"Low-dose imatinib mesylate leads to rapid induction of major molecular responses and achievement of complete molecular remission in FIP1L1-PDGFRA\u2013positive chronic eosinophilic leukemia.","volume":"109","author":"Jovanovic","year":"2007","journal-title":"Blood"},{"issue":"9","key":"ccg230005r6","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.3324\/haematol.11420","article-title":"The efficacy of imatinib mesylate in patients with FIP1L1-PDGFRa\u2013positive hypereosinophilic syndrome.","volume":"92","author":"Baccarani","year":"2007","journal-title":"Haematologica"},{"issue":"1","key":"ccg230005r7","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1182\/hematology.2022000368","article-title":"Available and emerging therapies for bona fide advanced systemic mastocytosis and primary eosinophilic neoplasms.","volume":"2022","author":"Gotlib","year":"2022","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"2","key":"ccg230005r8","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1111\/bjh.2008.141.issue-2","article-title":"A single weekly dose of imatinib is sufficient to induce and maintain remission of chronic eosinophilic leukaemia in FIP1L1-PDGFRA\u2013expressing patients.","volume":"141","author":"Helbig","year":"2008","journal-title":"Br J Haematol"},{"issue":"11","key":"ccg230005r9","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1002\/ajh.v95.11","article-title":"Epidemiology, clinical picture and long-term outcomes of FIP1L1-PDGFRA\u2013positive myeloid neoplasm with eosinophilia.","volume":"95","author":"Rohmer","year":"2020","journal-title":"Am J Hematol"},{"issue":"3","key":"ccg230005r10","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1182\/bloodadvances.2019001111","article-title":"Treatment-free remission in FIP1L1-PDGFRA\u2013positive myeloid\/lymphoid neoplasms with eosinophilia after imatinib discontinuation.","volume":"4","author":"Metzgeroth","year":"2020","journal-title":"Blood Adv"}],"container-title":["JAMA Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/articlepdf\/2810749\/jamaoncology_hameed_2023_cg_230005_1704491818.01563.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T16:01:54Z","timestamp":1705593714000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/fullarticle\/2810749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,1]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoncol.2023.4045","relation":{},"ISSN":["2374-2437"],"issn-type":[{"value":"2374-2437","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,1]]}}}